Evidence map›Paper›PMID 25380987›Full record

ArticleMolecular biotechnology2015

Zibibbo nero characterization, a red-wine grape revertant of muscat of Alexandria.

Gabriella De Lorenzis, Margherita Squadrito, Lucio Brancadoro, Attilio Scienza

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Identification of Red Grapevine Cultivars (Plants (Basel, Switzerland) · 2020
    Article
  3. The genetic basis of grape and wine aroma.Horticulture research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gabriella De LorenzisDipartimento di Scienze Agrarie e Ambientali, Università degli Studi di Milano, via Celoria 2, 20133, Milan, Italy, gabriella.delorenzis@unimi.it.
Margherita Squadrito
Lucio Brancadoro
Attilio Scienza
University of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Muscat of Alexandria is known in Italy as Zibibbo. Zibibbo nero, red-wine grapes, is a sport mutation of Zibibbo variety. A biochemical and molecular characterization of berry colour (VvMybA1 and VvMybA2 genes, Vitis vinifera MYeloBlastosis) and aroma Muscat (VvDXS gene, 1-deoxy-D-xylulose 5-phosphate synthase) traits in both Zibibbo cultivars was performed, as well as ampelographic and genetic identification analyses. Molecular investigations were performed also for two putative Zibibbo parents (Moscato Bianco and Triboto), in order to prove the white-to-red shift of the red-skinned mutant. Ampelographic and genetic analysis demonstrated the high similarity between Zibibbo and Zibibbo nero, as well as a comparable aroma profile, characterized mainly by high content of linalool, geranic acid and geraniol (about 70 %). The Zibibbo nero anthocyanin profile was characterized by a high proportion in cyanidin-3-O-glucoside (about 69.23 %). The molecular characterization of VvMybA1 and VvMybA2 locus detected non-functional alleles for white-skinned samples, while also the functional alleles were observed for red-skinned samples. About the VvDXS locus, the aromatic varieties showed the typical pattern of Muscat variety, while Triboto (Zibibbo parent) showed the non-Muscat-like flavour pattern. The colour locus structure of Zibibbo and its putative parents suggested that Zibibbo nero is a berry colour revertant of Zibibbo.

Indexed as

Quantitative Trait LociAnthocyaninsGenotypeMicrosatellite RepeatsMutationPlant ProteinsVitisWineAnthocyaninsPlant Proteins

Identifiers

PMID25380987
OpenAlexW2037468679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.